The Association of American Physicians and Surgeons argues “Defendant FDA has improperly exploited misunderstandings about the legality and prevalence of off-label uses of medication, in order to mislead courts, state medical boards, and the public into thinking there is anything improper about off-label prescribing”
The FDA Misled the Public About Ivermectin and Should Be Accountable in Court, Argues AAPS

Advertisement
Read the full article at the original publisher
aapsonline.org
Advertisement
Related stories



